Charlie Modlin - uventia

Charlie Modlin

Charlie Modlin

Charlie Modlin

Application Scientist

Lhasa-Limited

Charlie Modlin is an Application Scientist with Lhasa Limited based out of Charlotte, North Carolina. Charlie has been with Lhasa for approximately four years, and specializes in skin sensitization, carcinogenicity and oligonucleotide safety.

Charlie greatly enjoys traveling and speaking on the topics of in silico tools, the science of skin sensitization, and predictive toxicology. In his free time he enjoys playing with his dog, cat and chickens.

SPEAKED ABOUT:
4th Annual Extractables & Leachables
March 7, 2024
What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release?
Upcoming

DAY 1: MARCH 7th, 2024

SESSION: In silico approaches for the assessment of extractables and leachables

◆  Introduction to the assessment of E&Ls, particularly through an in silico lens.

◆  How in silico statistical models, expert-knowledge based models, and combined approaches can aid in E&L assessments.

◆  How Lhasa’s in silico solutions make use of combined model approaches to effectively predict hazard and potency of E&Ls.

◆  A worked case study demonstrating the implementation and efficacy of in silico approaches to estimate hazard and potency for E&Ls.

◆  The future of Lhasa’s solutions in the E&L space.

3rd Annual Extractables & Leachables
March 9, 2023
Learn innovative techniques for analyzing and testing for extractables and leachables in biopharmaceutical development. Recording of 2 days event sessions [20 video sessions].
Expired

DAY 2: MARCH 10th, 2023

SESSION: Using expert knowledge and machine learning to assess the mutagenicity and sensitisation potential of extractables and leachables

◆ 

Speaker Details
Speaker Details